The efficiency of high dose botulinum toxin type-A in the treatment of cerebral palsy
Objective: Cerebral palsy is the most common cause of severe physical disability in childhood. Botulinum toxin type A (BTX-A), has rapidly gained acceptance as a different treatment for spasticity. However, no consensus exists among clinicians about optimal dose of BTX-A in pediatric patients. Doses...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Modestum Publishing LTD
2014-03-01
|
| Series: | Journal of Clinical and Experimental Investigations |
| Subjects: | |
| Online Access: | http://www.jceionline.org/upload/sayi/20/JCEI-00938.pdf |